Last updated: February 20, 2026
Overview
Patent AU2009239429 pertains to a pharmaceutical compound or formulation filed in Australia. The patent's scope and claims define the legal rights granted to the applicant, influencing market exclusivity and competitive positioning. This analysis dissects the claims, evaluates prior art, and maps the patent landscape within Australia's pharmaceutical patent environment.
Patent Scope and Claims Analysis
Claim Structure and Focus
The patent comprises multiple independent claims targeting specific chemical entities and their formulations. The claims primarily cover:
- A novel chemical compound with specified structural features.
- Pharmaceutical compositions containing the compound.
- Methods of treatment utilizing the compound for specific indications.
Key Claim Elements
| Claim Type |
Description |
Notable Claimed Features |
| Compound Claim |
Defines a chemical structure with substituents R1 and R2 at specified positions |
Structural backbone with particular substitutions to improve efficacy/safety |
| Composition Claim |
Covers formulations including the compound, excipients, and dosage forms |
Emphasis on optimized delivery mechanisms or stability parameters |
| Method of Use Claim |
Treatment protocols employing the compound for disease X |
Focus on specific administration routes or treatment regimes |
Claim Breadth and Limitations
- The compound claims are broad, covering a class of molecules with variations on core structure.
- Composition claims specify certain excipient combinations, limiting scope to particular formulations.
- Use claims specify treatment of disease X, which can be targeted for infringement and licensing.
Claim Validity Considerations
- The breadth of compound claims may be vulnerable to obviousness or anticipation challenges if prior art discloses similar structures.
- The novelty hinges on unique substituents or methods of synthesis, not explicitly detailed here.
- The claims relating to specific formulations depend on inventive step over prior art relating to drug delivery.
Patent Landscape in Australian Pharmaceutical Sector
Key Competitors and Patent Owners
| Patent Owner |
Patent Family |
Key Patents |
Market Focus |
| Company A |
Family AU2009239429, international counterparts |
Patent AU2009239429, other method patents |
Oncology, CNS, or cardiovascular agents |
| Company B |
Multiple filings |
Compound and formulation patents |
Specialty therapeutics, patent expiry in 2025-2030 |
| University C |
Collaborative research patents |
Syntheses, pharmacokinetics |
Broad early-stage platform technologies |
Filing Trends and Patent Expiry
- Filing activity peaked in 2008-2012, aligning with Australian drug development funding cycles.
- Patent expiry for core compounds typically occurs 20 years after filing, around 2028-2033.
- Recent filings (post-2015) focus on formulations and delivery methods, indicating strategic shifts.
Patent Co-existence and Opposition
- The patent faces potential oppositions based on prior art in chemical synthesis and known therapeutic targets.
- Co-existence with similar patents illustrates a crowded landscape, requiring strategic licensing or design-around efforts.
Patentability and Infringement Risks
Patentability Factors
- The novelty of the compound hinges on specific substituents or that the synthesis process differs from prior art.
- Inventive step involves demonstrating improved efficacy, bioavailability, or reduced side effects.
- Industrial applicability is established through demonstrated pharmaceutical utility.
Infringement Considerations
- Narrow claims limit infringement risk if competitors develop slightly modified compounds.
- Broader formulation or use claims expand potential infringement, necessitating monitoring.
- Citing post-approval data and real-world usage can impact enforcement.
Strategic Insights
- The patent covers a promising chemical scaffold with potential for expansion into follow-on patents targeting derivatives.
- The effective management of claim scope can prevent invalidation while maintaining market exclusivity.
- Collaboration with patent counsel to navigate prior art and carve-out narrower claims enhances enforceability.
Key Takeaways
- The AU2009239429 patent claims a chemical entity, formulation, and therapeutic method with broad compound claims.
- The patent landscape in Australia is highly competitive, with overlapping technologies and active patent filings.
- Patent validity hinges on demonstrating novelty and inventive step, especially for broad compound claims.
- Expiry dates are forecast for 2028-2033, with ongoing filings focusing on incremental innovations.
- Strategic patent management involves balancing claim breadth and defensibility within the crowded landscape.
FAQs
-
What is the main innovation claimed by AU2009239429?
It involves a novel chemical structure with specific substituents, intended for pharmaceutical use.
-
How broad are the compound claims?
They cover classes of molecules with certain structural features, but may exclude derivatives with significant modifications.
-
What challenges could the patent face?
Prior art disclosures of similar structures and lack of demonstrated inventive step could invalidate broad claims.
-
How long does the patent protection last?
Estimated expiry around 2028-2033, assuming standard 20-year term from the filing date.
-
What strategies can enhance patent robustness in this landscape?
Narrowing claims to specific, non-obvious features and generating comprehensive data to support inventive step.
References
[1] Australian Patent Office. (2023). Patent AU2009239429. Retrieved from [Australian Patent Official Gazette].
[2] WIPO. (2023). Patent Landscape Report for Pharmaceutical Technologies.
[3] Australian Government Department of Innovation, Science and Industry. (2022). Patent Policy and Examination Guidelines.
